With new regulations taking effect this fall and more advanced technologies now available, the state of clinical development of new drugs and devices is definitely changing for the better.On November 1, ...
Company: Gaussian, Inc.
Email Aleen Frisch, Ph.D.
Your Full Name:
Accurate optimizations on large molecules now possible.